A NON-endemic spread of monkeypox has been reported in multiple countries – a phenomenon that has never happened before. The Centers for Disease Control and Prevention and the World Health Organization are developing plans for potential outbreaks – what are the 101s on this disease for healthcare providers?The GameChanger Most cases of monkeypox are self-limiting, but death rates up to 10% have been reported, particularly in children and immunosuppressed patients. Treatment options for monkeypox exist but have not been evaluated in large studies to prove efficacy or safety.  Show Segments 00:00 – Introductions 01:24 – Monkeypox Background  08:29 – Monkeypox Presentation  09:32 – Combating & Treating Monkeypox 21:21 – Closing Remarks  Host Geoff Wall, PharmD, BCPS, FCCP, CGP Professor of Pharmacy Practice, Drake University Internal Medicine/Critical Care, UnityPoint Health References and resources:CDC. Monkeypox and Smallpox Vaccine Guidance. WHO. Multi-country monkeypox outbreaks in non-endemic countries. Clinical features and management of human monkeypox: a retrospective observational study in the UK.Redeem your CPE or CME creditCPE (Pharmacist)CME (Physician)Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode) Pharmacists: Get a Membership Prescribers: Get a Membership Continuing Education Information:Learning Objectives:1. Describe the symptoms and signs of monkeypox2. Discuss current status of vaccines against monkeypox in the US 0.05 CEU | 0.5 HrsACPE UAN: 0107-0000-22-276-H01-PInitial release date: 07/25/22Expiration date: 07/25/2023Additional CPE & CME details can be found hereFollow CEimpact on Social Media:LinkedInInstagram

Ver todos los episodios